MTOR and breast neoplasm: Moreover, the underlying mechanism of antitumor effects regarding Pt/GF@Lipo‐TPP nanocatalysts was chiefly through promoting the generation of ROS, stimulating mitochondrial dysfunction, downregulating AKT/mTOR signaling, and causing cell autophagic death in breast tumor cells.